Natural Biocon India Ltd Stock Price Today (NSE: NATURAL)
Fundamental Score
Natural Biocon India Ltd Share Price Live NSE/BSE & Institutional Fundamental Analysis
Natural Biocon India Ltd share price today is ₹4.29, up +0.00% on NSE/BSE as of 17 February 2026. Natural Biocon India Ltd (NATURAL) is a Small-cap company in the Pesticides & Agrochemicals sector with a market capitalisation of ₹10.49 (Cr). The 52-week high for NATURAL share price is ₹N/A and the 52-week low is ₹N/A. The company has a Return on Equity (ROE) of 0.18% and a debt-to-equity ratio of 0.01.
Natural Biocon India Ltd Share Price Chart — NSE/BSE Historical Performance
Returns & Performance
ROE
ROCE
OPM (5Y)
Div Yield
Natural Biocon India Ltd Valuation Check
P/E Ratio
Industry P/E
Market Cap
Growth Engine
Profit Growth (Q)
Sales Growth (Q)
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Balance Sheet Health
Debt to Equity
Int. Coverage
Free Cash Flow (5Y)
Shareholding
Promoter
FII
DII
Pledged
Institutional Deep-Dive
Bull Run Research Hub
Financial Analysis of Natural Biocon Share Price: A Cautionary Overview
The agrochemicals and pesticides sector, while crucial for global food security, faces increasing scrutiny regarding environmental impact and regulatory compliance, demanding robust innovation and sustainable practices from its players. This analysis focuses on a financial risk assessment of the Natural Biocon share price, currently trading at ₹4.13, as part of a broader fundamental audit verified by Sweta Mishra. The audit includes 80 parameters. Considering the available data, the absence of a Price-to-Earnings (PE) ratio raises immediate concerns about profitability or earnings stability.
The Return on Capital Employed (ROCE) of 0.27% is significantly low. This indicates that Natural Biocon is generating minimal returns from its invested capital. Such a low ROCE directly impacts the company's competitive advantage, often referred to as its economic "moat." A strong moat typically relies on high profitability and efficient capital utilization. With such a low ROCE, Natural Biocon appears vulnerable to competitors and struggles to reinvest effectively for future growth. The sustainability of its operations is also questionable at this level.
Comparing Natural Biocon India Ltd with peers such as
Phyto Chem India Limited is essential. While comprehensive information regarding management quality is limited, the significant difference in ROCE, if Phyto Chem India Limited demonstrates a superior figure, could suggest potential disparities in operational efficiency and strategic decision-making. Ultimately, Management quality differences should be investigated with proper research, including examining experience, track record, and board quality.In conclusion, observing the current data suggests caution regarding the financial stability of Natural Biocon. The absence of a PE ratio, combined with the exceptionally low ROCE of 0.27%, warrants careful scrutiny. Further investigation into its profitability, debt levels, and cash flow is necessary to form a comprehensive risk assessment. This analysis is observational and does not constitute investment advice.
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Natural Biocon India Ltd Fundamental Analysis & Valuation Benchmarking
Educational evaluation of NATURAL across key market metrics for learning purposes.
Positive Indicators
4 factors identified
Excellent EPS Growth (17.30% CAGR)
Observation: Outstanding 5-year earnings per share compound growth.
Analysis: EPS CAGR >15% indicates strong wealth creation potential.
Strong Profit Growth Track Record (20.11% CAGR)
Observation: Consistent 5-year profit compound annual growth rate.
Analysis: Profit CAGR >15% demonstrates scalable business model.
Conservative Debt Levels (D/E: 0.01)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
7 factors identified
Below-Average Return on Equity (0.18%)
Observation: Returns on equity are below industry benchmarks.
Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.
Suboptimal ROCE (0.27%)
Observation: Returns on capital employed are below expectations.
Analysis: ROCE <10% suggests potential inefficiencies in capital allocation.
Margin Pressure Concerns (2.65%)
Observation: Operating margins are below industry standards.
Analysis: OPM <5% may indicate pricing pressures or cost management challenges.
Profit Decline Concern (-120.00%)
Observation: Significant year-over-year profit contraction observed.
Analysis: Declining profitability requires investigation into underlying causes.
Revenue Contraction (-100.00%)
Observation: Sales decline may indicate market challenges or competitive pressures.
Analysis: Negative revenue growth requires analysis of market conditions.
Low Promoter Commitment (9.36%)
Observation: Reduced promoter stake may indicate limited confidence.
Analysis: Low promoter holding may raise questions about management commitment.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
Natural Biocon India Ltd Financial Statements
Comprehensive financial data for Natural Biocon India Ltd including income statement, balance sheet and cash flow
About NATURAL (Natural Biocon India Ltd)
Natural Biocon India Ltd (NATURAL) is listed on the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) of India. The company operates in the Pesticides & Agrochemicals sector with a current market capitalisation of ₹10.49 (Cr). Natural Biocon India Ltd has delivered a Return on Equity (ROE) of 0.18% and a ROCE of 0.27%. The debt-to-equity ratio stands at 0.01, reflecting the company's capital structure. Investors tracking NATURAL share price can monitor key metrics including P/E ratio, promoter holding of 9.36%, and quarterly earnings growth.
Company Details
Key Leadership
Latest News
NATURAL Share Price: Frequently Asked Questions
What is the current share price of Natural Biocon India Ltd (NATURAL)?
As of 17 Feb 2026, 10:17 am IST, Natural Biocon India Ltd share price is ₹4.29. The NATURAL stock has a market capitalisation of ₹10.49 (Cr) on NSE/BSE.
Is NATURAL share price Overvalued or Undervalued?
NATURAL share price is currently trading at a P/E ratio of 0.00x, compared to the industry average of 29.36x. Based on this relative valuation, the Natural Biocon India Ltd stock appears to be Fairly Valued against its sector peers.
What is the 52-week high and low of NATURAL share price?
The 52-week high of NATURAL share price is ₹N/A and the 52-week low is ₹N/A.
What factors affect the Natural Biocon India Ltd share price?
Key factors influencing NATURAL share price include quarterly earnings growth (Sales Growth: -100.00%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).
Is Natural Biocon India Ltd a good stock for long-term investment?
Natural Biocon India Ltd shows a 5-year Profit Growth of 20.11% and an ROE of 0.18%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.01 before investing in NATURAL shares.
How does Natural Biocon India Ltd compare with its industry peers?
Natural Biocon India Ltd competes with major peers in the Pesticides & Agrochemicals. Investors should compare NATURAL share price P/E of 0.00x and ROE of 0.18% against the industry averages to determine competitive standing.
What is the P/E ratio of NATURAL and what does it mean?
NATURAL share price has a P/E ratio of N/Ax compared to the industry average of 29.36x. Investors pay ₹N/A for every ₹1 of annual earnings.
How is NATURAL performing according to Bull Run's analysis?
NATURAL has a Bull Run fundamental score of 10.5/100, indicating concerns requiring careful analysis. This comprehensive rating is based on 15+ financial parameters.
What sector and industry does NATURAL belong to?
NATURAL operates in the Pesticides & Agrochemicals industry. This classification helps understand the competitive landscape and sector-specific trends affecting Natural Biocon India Ltd share price.
What is Return on Equity (ROE) and why is it important for NATURAL?
NATURAL has an ROE of 0.18%, which suggests challenges in generating returns from shareholders equity. ROE measures how efficiently Natural Biocon India Ltd generates profits from shareholders capital.
How is NATURAL debt-to-equity ratio and what does it indicate?
NATURAL has a debt-to-equity ratio of 0.01, which indicates conservative financing with low financial risk.
What is NATURAL dividend yield and is it a good dividend stock?
NATURAL offers a dividend yield of 0.00%, meaning you receive ₹0.00 annual dividend for every ₹100 invested in Natural Biocon India Ltd shares.
How has NATURAL share price grown over the past 5 years?
NATURAL has achieved 5-year growth rates of: Sales Growth N/A%, Profit Growth 20.11%, and EPS Growth 17.30%.
What is the promoter holding in NATURAL and why does it matter?
Promoters hold 9.36% of NATURAL shares, with 0.00% pledged. High promoter holding often indicates strong management confidence in Natural Biocon India Ltd.
What is NATURAL market capitalisation category?
NATURAL has a market capitalisation of ₹10 crores, placing it in the Small-cap category.
How volatile is NATURAL stock?
NATURAL has a beta of N/A. A beta > 1 suggests the Natural Biocon India Ltd stock is more volatile than the market, while a beta < 1 suggests it is less volatile.
What is NATURAL operating profit margin trend?
NATURAL has a 5-year average Operating Profit Margin (OPM) of 2.65%, indicating the company's operational efficiency.
How is NATURAL quarterly performance?
Recent quarterly performance shows Natural Biocon India Ltd YoY Sales Growth of -100.00% and YoY Profit Growth of -120.00%.
What is the institutional holding pattern in NATURAL?
NATURAL has FII holding of 0.00% and DII holding of 0.00%. Significant institutional holding often suggests professional confidence in the Natural Biocon India Ltd stock.